| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8225173 | International Journal of Radiation Oncology*Biology*Physics | 2012 | 4 Pages |
Abstract
Our data showed HDR-ICR is an effective modality for CIN 3 and CIS patients presenting with poor histologic factors after excisional procedures. HDR-ICR should be considered as a definitive treatment in CIN 3 and CIS patients with possible residual disease after undergoing excisional procedures.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Yong Bae MD, Young Tae MD, Nam Hoon MD, Woong Sub MD, Sunghoon MD, Sang Wun MD, Eun Ji MD, Gwi Eon MD,